Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1345/aph.1D368a | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In response to "Title: Letter to the Editor in response to the article 'Efficacy and safety of HIF prolyl hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis'".
Pharmacol Res
January 2021
Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China; Renal Research Institution of Beijing University of Chinese Medicine, Beijing, China; Department of Endocrinology, Nephropathy of Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China. Electronic address:
Letter to the Editor in response to the article "Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis".
Pharmacol Res
January 2021
Akebia Therapeutics, Inc., 245 First Street, Cambridge, MA, 02142, USA.
Erythropoietin in Preterm Infants.
N Engl J Med
May 2020
Copenhagen University Hospital, Copenhagen, Denmark.
Analysis of Other Confounding Factors Is Mandatory before Considering That Long-Acting Erythropoiesis Stimulating Agents Are Deleterious to Patients on Dialysis.
J Am Soc Nephrol
September 2019
Division of Nephrology, Dialysis and Transplantation, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!